Details of Disease
General Information of Disease (ID: DISOX57C)
Disease Name | ALG1-congenital disorder of glycosylation | |||||
---|---|---|---|---|---|---|
Synonyms |
CDG Ik; congenital disorder of glycosylation, type Ik; CDG 1K; ALG1-CDG (CDG-Ik); congenital disorder of glycosylation type Ik; carbohydrate deficient glycoprotein syndrome type Ik; congenital disorder of glycosylation type 1k; ALG1-congenital disorder of glycosylation; CDG-Ik; CDG syndrome type Ik; CDG1K; ALG1-CDG; mannosyltransferase 1 deficiency
|
|||||
Definition |
A severe form of congenital disorders of N-linked glycosylation characterized by severe developmental and psychomotor delay, muscular hypotonia, intractable early-onset seizures, and microcephaly. Additional features include altered blood coagulation with a high probability of hemorrhages or thromboses, nephrotic syndrome, ascites, hepatomegaly, cardiomyopathy, ocular manifestations (strabismus, nystagmus), and immunodeficiency. The disease is caused by loss-of-function mutations in the gene ALG1 (16p13.3).
|
|||||
Disease Hierarchy | ||||||
Disease Identifiers | ||||||
Molecular Interaction Atlas (MIA) of This Disease
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
This Disease Is Related to 1 DOT Molecule(s)
|
|||||||||||||||||||||||||